Inflammatory Chemokines in Atherosclerosis
- PMID: 33503867
- PMCID: PMC7911854
- DOI: 10.3390/cells10020226
Inflammatory Chemokines in Atherosclerosis
Abstract
Atherosclerosis is a long-term, chronic inflammatory disease of the vessel wall leading to the formation of occlusive or rupture-prone lesions in large arteries. Complications of atherosclerosis can become severe and lead to cardiovascular diseases (CVD) with lethal consequences. During the last three decades, chemokines and their receptors earned great attention in the research of atherosclerosis as they play a key role in development and progression of atherosclerotic lesions. They orchestrate activation, recruitment, and infiltration of immune cells and subsequent phenotypic changes, e.g., increased uptake of oxidized low-density lipoprotein (oxLDL) by macrophages, promoting the development of foam cells, a key feature developing plaques. In addition, chemokines and their receptors maintain homing of adaptive immune cells but also drive pro-atherosclerotic leukocyte responses. Recently, specific targeting, e.g., by applying cell specific knock out models have shed new light on their functions in chronic vascular inflammation. This article reviews recent findings on the role of immunomodulatory chemokines in the development of atherosclerosis and their potential for targeting.
Keywords: atherosclerosis; cardiovascular disease; chemokine receptors; chemokines; inflammation; mouse models.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Chemokines in atherosclerosis: proceedings resumed.Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):742-50. doi: 10.1161/ATVBAHA.113.301655. Epub 2014 Jan 16. Arterioscler Thromb Vasc Biol. 2014. PMID: 24436368 Review.
-
Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?Curr Pharm Des. 2007;13(10):1039-52. doi: 10.2174/138161207780487584. Curr Pharm Des. 2007. PMID: 17430167 Review.
-
Atherosclerosis as an inflammatory disease.Curr Pharm Des. 2012;18(28):4266-88. doi: 10.2174/138161212802481237. Curr Pharm Des. 2012. PMID: 22390643 Review.
-
Chemokines in the vascular inflammatory response of atherosclerosis.Cardiovasc Res. 2010 May 1;86(2):192-201. doi: 10.1093/cvr/cvp391. Epub 2009 Dec 9. Cardiovasc Res. 2010. PMID: 20007309 Review.
-
Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases.Mech Ageing Dev. 2024 Aug;220:111944. doi: 10.1016/j.mad.2024.111944. Epub 2024 May 21. Mech Ageing Dev. 2024. PMID: 38782074 Review.
Cited by
-
Immunological perspectives on atherosclerotic plaque formation and progression.Front Immunol. 2024 Sep 27;15:1437821. doi: 10.3389/fimmu.2024.1437821. eCollection 2024. Front Immunol. 2024. PMID: 39399488 Free PMC article. Review.
-
Platelets, a Key Cell in Inflammation and Atherosclerosis Progression.Cells. 2022 Mar 17;11(6):1014. doi: 10.3390/cells11061014. Cells. 2022. PMID: 35326465 Free PMC article. Review.
-
Immunity in Atherosclerosis: Focusing on T and B Cells.Int J Mol Sci. 2021 Aug 4;22(16):8379. doi: 10.3390/ijms22168379. Int J Mol Sci. 2021. PMID: 34445084 Free PMC article. Review.
-
Investigating the therapeutic effects and mechanisms of Carthamus tinctorius L.-derived nanovesicles in atherosclerosis treatment.Cell Commun Signal. 2024 Mar 12;22(1):178. doi: 10.1186/s12964-024-01561-6. Cell Commun Signal. 2024. PMID: 38475787 Free PMC article.
-
Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy?Biomolecules. 2024 Dec 20;14(12):1637. doi: 10.3390/biom14121637. Biomolecules. 2024. PMID: 39766344 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical